Hon CHRIS HIPKINS: I was asked by Stuff what the status of our discussions with Novavax was. I confirmed to them that we have an advance purchase agreement with Novavax; that we have the ability to source doses of Novavax in the first quarter of next year, should it be required for a booster campaign; and that the preliminary information that we're getting, and it is just ongoing discussions, from our technical experts is that they think that Novavax is shaping up well as an option for New Zealand. But no decisions have been made.